MX9803706A - Metodo para transferir genes dentro de celulas objetivo, con retrovirus. - Google Patents
Metodo para transferir genes dentro de celulas objetivo, con retrovirus.Info
- Publication number
- MX9803706A MX9803706A MX9803706A MX9803706A MX9803706A MX 9803706 A MX9803706 A MX 9803706A MX 9803706 A MX9803706 A MX 9803706A MX 9803706 A MX9803706 A MX 9803706A MX 9803706 A MX9803706 A MX 9803706A
- Authority
- MX
- Mexico
- Prior art keywords
- retrovirus
- target cells
- gene introduction
- effective amount
- functional substance
- Prior art date
Links
- 241001430294 unidentified retrovirus Species 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 239000000126 substance Substances 0.000 abstract 4
- 239000011324 bead Substances 0.000 abstract 1
- 230000003028 elevating effect Effects 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
- C12N9/1088—Glutathione transferase (2.5.1.18)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13045—Special targeting system for viral vectors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se da a conocer un método para aumentar la eficiencia de la transferencia de genes en células objetivo, con un retrovirus. En este método, las células objetivo son infectadas con el retrovirus, en la presencia de o una mezcla de una cantidad efectiva de un material funciona, que tiene dominios de union de retrovirus, y una cantidad efectiva de otro material funcional, que tiene dominios de union de las células objetivo o una cantidad efectiva de un material funcional, que tiene estos dominios de union en la misma molécula. Los materiales funcionales se pueden usar sin inmovilizacion con inmovilizados sobre globulos. Este método es util, por ejemplo, en la terapia de genes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29438295 | 1995-11-13 | ||
JP5184796 | 1996-03-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9803706A true MX9803706A (es) | 1998-09-30 |
Family
ID=26392431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9803706A MX9803706A (es) | 1995-11-13 | 1998-05-11 | Metodo para transferir genes dentro de celulas objetivo, con retrovirus. |
Country Status (13)
Country | Link |
---|---|
US (5) | US6472204B1 (es) |
EP (1) | EP0870839B1 (es) |
JP (1) | JP3343357B2 (es) |
KR (2) | KR100353115B1 (es) |
CN (1) | CN100390290C (es) |
AT (1) | ATE325884T1 (es) |
AU (1) | AU709831B2 (es) |
CA (1) | CA2235629A1 (es) |
DE (1) | DE69636122T2 (es) |
EA (3) | EA003204B1 (es) |
ES (1) | ES2259182T3 (es) |
MX (1) | MX9803706A (es) |
WO (1) | WO1997018318A1 (es) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7083979B1 (en) * | 1994-03-25 | 2006-08-01 | Indiana University Foundation | Methods for enhanced retroviral-mediated gene transfer |
DE69638058D1 (de) | 1995-06-15 | 2009-11-26 | Crucell Holland Bv | Verpackungssysteme für humane rekombinante Adenoviren zur Gentherapie |
DE69636124T2 (de) * | 1995-09-29 | 2006-12-21 | Indiana University Research And Technology Corp., Bloomington | Verfahren zum verbesserten virusvermittelten dns-transfer unter verwendung von molekülen mit virus- und zellbindenden domänen |
TWI239352B (en) * | 1997-07-23 | 2005-09-11 | Takara Bio Inc | Gene transfer method with the use of serum-free medium |
JP2001523468A (ja) * | 1997-11-14 | 2001-11-27 | セダーシナイ メディカル センター | トランスジェニック種の産生のための雄性生殖細胞のトランスフェクションおよび移入 |
EP1094114B1 (en) * | 1998-07-01 | 2007-01-03 | Takara Bio Inc. | Gene transfer methods |
AU1458200A (en) * | 1998-10-31 | 2000-05-22 | University Of Medicine And Dentistry Of New Jersey | A myeloid precursor cell useful for gene therapy and for modulation of immune responses |
KR100674140B1 (ko) * | 1999-03-23 | 2007-01-26 | 다카라 바이오 가부시키가이샤 | 유전자 치료제 |
US7345019B1 (en) | 1999-04-13 | 2008-03-18 | The Kenneth S. Warren Institute, Inc. | Modulation of excitable tissue function by peripherally administered erythropoietin |
US7309687B1 (en) | 1999-04-13 | 2007-12-18 | The Kenneth S. Warren Institute, Inc. | Methods for treatment and prevention of neuromuscular and muscular conditions by peripherally administered erythropoietin |
US7297680B2 (en) | 1999-04-15 | 2007-11-20 | Crucell Holland B.V. | Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content |
US6855544B1 (en) * | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
US7604960B2 (en) * | 1999-04-15 | 2009-10-20 | Crucell Holland B.V. | Transient protein expression methods |
US8236561B2 (en) * | 1999-04-15 | 2012-08-07 | Crucell Holland B.V. | Efficient production of IgA in recombinant mammalian cells |
US20050164386A1 (en) * | 1999-04-15 | 2005-07-28 | Uytdehaag Alphonsus G. | Overexpression of enzymes involved in post-translational protein modifications in human cells |
US20050170463A1 (en) * | 1999-04-15 | 2005-08-04 | Abraham Bout | Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins |
GB9912965D0 (en) * | 1999-06-03 | 1999-08-04 | Oxford Biomedica Ltd | In vivo selection method |
AU5958000A (en) * | 1999-07-08 | 2001-01-30 | Connie Jean Eaves | Method to improve viral infection |
US7521220B2 (en) * | 1999-11-26 | 2009-04-21 | Crucell Holland B.V. | Production of vaccines |
US7192759B1 (en) * | 1999-11-26 | 2007-03-20 | Crucell Holland B.V. | Production of vaccines |
US7527961B2 (en) * | 1999-11-26 | 2009-05-05 | Crucell Holland B.V. | Production of vaccines |
WO2002018550A1 (en) | 2000-08-25 | 2002-03-07 | The General Hospital Corporation | Selective precipitation of viruses |
US6531121B2 (en) | 2000-12-29 | 2003-03-11 | The Kenneth S. Warren Institute, Inc. | Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
PA8536201A1 (es) | 2000-12-29 | 2002-08-29 | Kenneth S Warren Inst Inc | Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina |
DE60232149D1 (de) * | 2001-06-20 | 2009-06-10 | Dainippon Sumitomo Pharma Co | Verfahren zur förderung des nukleinsäuretransfers |
JP2005052001A (ja) * | 2001-07-05 | 2005-03-03 | Takara Bio Inc | 遺伝子治療剤 |
ATE429486T1 (de) | 2001-08-15 | 2009-05-15 | Takara Bio Inc | Expansionskulturverfahren für antigenspezifische zytotoxische t-lymphozyten |
ATE384785T1 (de) * | 2001-12-07 | 2008-02-15 | Crucell Holland Bv | Herstellung von viren, virusisolaten, und impfstoffen |
TWI334442B (en) * | 2002-03-25 | 2010-12-11 | Takara Bio Inc | Process for producing cytotoxic lymphocyte |
US20100143442A1 (en) | 2003-02-05 | 2010-06-10 | Queensland University Of Technology | Growth factor complexes and modulation of cell migration and growth |
US20040220085A1 (en) * | 2003-05-02 | 2004-11-04 | Jasbir Sandhu | Compositions for nucleic acid delivery |
US20040219099A1 (en) * | 2003-05-02 | 2004-11-04 | Jasbir Sandhu | Method for the treatment of tumors |
DK1623023T3 (da) | 2003-05-09 | 2009-03-02 | Crucell Holland Bv | Kulturer af E1-immortaliserede celler og fremgangsmåder til dyrkning deraf til forögelse af produktudbytter derfra |
ATE469920T1 (de) * | 2003-05-23 | 2010-06-15 | Crucell Holland Bv | Herstellung von rekombinanten igm in den per.c6 zellen |
FR2857598A1 (fr) * | 2003-07-18 | 2005-01-21 | Inst Nat Sante Rech Med | Composes anti-angiogeniques, composition pharmaceutique les comprenant, et leur utilisation |
KR101331746B1 (ko) | 2003-08-22 | 2013-11-20 | 다카라 바이오 가부시키가이샤 | 세포 상해성 림프구의 제조 방법 |
GB0410130D0 (en) * | 2004-05-06 | 2004-06-09 | Molmed Spa | Cell preparation |
JP5546716B2 (ja) * | 2004-09-29 | 2014-07-09 | タカラバイオ株式会社 | レトロウイルスベクター産生用細胞 |
EP1847596B1 (en) | 2005-02-07 | 2012-05-23 | Takara Bio, Inc. | Method of retrovirus storage |
EP1892294A4 (en) | 2005-06-15 | 2010-04-14 | Takara Bio Inc | METHOD OF TRANSFERRING GENES IN FAT CELLS OR PRECURSOR FAT CELLS |
WO2007012144A1 (en) * | 2005-07-29 | 2007-02-01 | Australian Stem Cell Centre Limited | Compositions and methods for growth of pluripotent cells |
US8889844B2 (en) | 2005-08-16 | 2014-11-18 | Takara Bio Inc. | Nucleic acid for treatment or prevention of immunodeficiency virus infection |
KR101279172B1 (ko) | 2005-08-17 | 2013-06-27 | 다카라 바이오 가부시키가이샤 | 림프구의 제조 방법 |
JP4741906B2 (ja) * | 2005-08-31 | 2011-08-10 | タカラバイオ株式会社 | リンパ球の製造方法 |
EP1939278A4 (en) | 2005-09-30 | 2009-06-03 | Takara Bio Inc | METHOD FOR PRODUCING A T CELL POPULATION |
WO2007142300A1 (ja) | 2006-06-09 | 2007-12-13 | Takara Bio Inc. | リンパ球の製造方法 |
WO2008133137A1 (ja) | 2007-04-20 | 2008-11-06 | Takara Bio Inc. | 遺伝子治療のためのベクター |
WO2009119793A1 (ja) | 2008-03-27 | 2009-10-01 | タカラバイオ株式会社 | 遺伝子導入細胞の製造方法 |
CN102144027B (zh) | 2008-07-07 | 2016-04-06 | 宝生物工程株式会社 | 生产多能干细胞的方法 |
WO2010080032A2 (en) * | 2009-01-09 | 2010-07-15 | Stichting Het Nederlands Kanker Instituut | Bead-assisted viral transduction |
EP2471901A4 (en) | 2009-08-25 | 2013-06-26 | Takara Bio Inc | PROCESS FOR PRODUCING T-CELL POPULATION IN THE PRESENCE OF RETINOIC ACID |
KR101679602B1 (ko) | 2009-09-11 | 2016-11-25 | 다카라 바이오 가부시키가이샤 | 내추럴킬러 세포의 제조방법 |
CN102725308A (zh) * | 2009-11-30 | 2012-10-10 | 昆士兰技术大学 | 纤连蛋白:生长因子嵌合物 |
US9228206B2 (en) | 2010-06-30 | 2016-01-05 | Takara Bio Inc. | Method for gene transfer |
US8841126B2 (en) | 2010-06-30 | 2014-09-23 | Takara Bio Inc. | Method for gene transfer |
US9861681B2 (en) | 2013-04-18 | 2018-01-09 | The United States of America as represented by the Secretary of the Army, on behalf of the United States Army Medical Research Institute of Infectious Diseases | Therapeutic compositions for neutralizing type I interferons, and methods of use |
CN109790536A (zh) | 2016-07-29 | 2019-05-21 | 宝生物工程株式会社 | 用于干细胞产生的纤连蛋白片段 |
WO2018053463A1 (en) | 2016-09-19 | 2018-03-22 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Artificial antigen presenting cells for genetic engineering of immune cells |
CN108103045B (zh) * | 2016-11-25 | 2022-10-04 | 丰益(上海)生物技术研发中心有限公司 | 脂肪酶及其应用 |
WO2018156735A1 (en) * | 2017-02-22 | 2018-08-30 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Bispecific antibody for cancer immunotherapy |
EP3397998A4 (en) | 2017-02-22 | 2019-04-17 | Lumus Ltd. | OPTICAL LIGHT GUIDE ASSEMBLY |
JP7173994B2 (ja) | 2018-01-25 | 2022-11-17 | タカラバイオ株式会社 | リンパ球の製造方法 |
US10983264B2 (en) | 2019-01-24 | 2021-04-20 | Lumus Ltd. | Optical systems including light-guide optical elements with two-dimensional expansion |
KR20220119479A (ko) * | 2019-12-30 | 2022-08-29 | 생-고뱅 퍼포먼스 플라스틱스 코포레이션 | 세포 형질 도입을 위한 컨테이너 및 방법 |
CN113444167B (zh) * | 2021-07-15 | 2022-09-30 | 陕西巨子生物技术有限公司 | 重组人胶原蛋白多肽及其应用 |
CN114634984A (zh) * | 2022-02-02 | 2022-06-17 | 复旦大学 | 一种脑胶质瘤生物标记物mlkl基因及其应用 |
WO2023213969A1 (en) * | 2022-05-05 | 2023-11-09 | Juno Therapeutics Gmbh | Viral-binding protein and related reagents, articles, and methods of use |
CN114965839A (zh) * | 2022-05-11 | 2022-08-30 | 朗肽生物制药股份有限公司 | 人碱性成纤维细胞生长因子的肽图分析方法 |
US20240167019A1 (en) * | 2022-11-18 | 2024-05-23 | Saint-Gobain Performance Plastics Corporation | Aptamers, containers and methods for cell transduction |
CN117603343B (zh) * | 2024-01-19 | 2024-04-26 | 四川大学 | 阻断bFGF的胶原来源天然短肽及应用 |
CN117645664A (zh) * | 2024-01-29 | 2024-03-05 | 英特菲尔(成都)生物制品有限责任公司 | 重组人纤连蛋白标准品及其制备方法、鉴定方法与应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8516421D0 (en) * | 1985-06-28 | 1985-07-31 | Biotechnology Interface Ltd | Fibronectins |
US5026839A (en) | 1985-12-17 | 1991-06-25 | Synergen, Inc | DNA encoding a basic fibroblast growth factor |
US4994559A (en) | 1985-12-17 | 1991-02-19 | Synergen, Inc. | Human basic fibroblast growth factor |
JP2770926B2 (ja) * | 1985-12-17 | 1998-07-02 | サイナーゲン インコーポレーテッド | 毛管内皮細胞プロテアーゼ合成、dna合成および遊走を促進することの出来るヒト胎盤血管形成誘導因子 |
US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US5492890A (en) | 1990-12-03 | 1996-02-20 | The Scripps Research Institute | Polypeptides for promoting cell attachment |
DE4110409C2 (de) * | 1991-03-29 | 1999-05-27 | Boehringer Ingelheim Int | Neue Protein-Polykation-Konjugate |
JP2829405B2 (ja) * | 1991-10-14 | 1998-11-25 | 寳酒造株式会社 | 機能性ポリペプチド |
SE503225C2 (sv) * | 1991-10-30 | 1996-04-22 | Leif Lindholm Konsult Ab | Virus-antikroppskomplex för införing av virus i mammalieceller |
CH685803A5 (fr) * | 1992-06-09 | 1995-10-13 | Francis Verdan | Bâton d'alun fixé dans un étui. |
GB9223084D0 (en) * | 1992-11-04 | 1992-12-16 | Imp Cancer Res Tech | Compounds to target cells |
US5686278A (en) | 1994-03-25 | 1997-11-11 | Indiana University Foundation | Methods for enhanced retrovirus-mediated gene transfer |
JPH1029952A (ja) | 1996-07-16 | 1998-02-03 | Takara Shuzo Co Ltd | ヒト免疫不全ウイルス感染の制御用組成物および制御方法 |
-
1996
- 1996-11-07 US US08/809,156 patent/US6472204B1/en not_active Expired - Fee Related
- 1996-11-07 JP JP51873197A patent/JP3343357B2/ja not_active Expired - Fee Related
- 1996-11-07 EA EA200001110A patent/EA003204B1/ru not_active IP Right Cessation
- 1996-11-07 KR KR10-1998-0703457A patent/KR100353115B1/ko not_active IP Right Cessation
- 1996-11-07 CA CA002235629A patent/CA2235629A1/en not_active Abandoned
- 1996-11-07 AU AU75058/96A patent/AU709831B2/en not_active Ceased
- 1996-11-07 DE DE69636122T patent/DE69636122T2/de not_active Expired - Lifetime
- 1996-11-07 EA EA199800369A patent/EA003195B1/ru not_active IP Right Cessation
- 1996-11-07 WO PCT/JP1996/003254 patent/WO1997018318A1/ja active IP Right Grant
- 1996-11-07 CN CNB961996137A patent/CN100390290C/zh not_active Expired - Fee Related
- 1996-11-07 EA EA200200837A patent/EA004928B1/ru not_active IP Right Cessation
- 1996-11-07 AT AT96937515T patent/ATE325884T1/de not_active IP Right Cessation
- 1996-11-07 ES ES96937515T patent/ES2259182T3/es not_active Expired - Lifetime
- 1996-11-07 KR KR10-2001-7008355A patent/KR100395420B1/ko not_active IP Right Cessation
- 1996-11-07 EP EP96937515A patent/EP0870839B1/en not_active Expired - Lifetime
-
1998
- 1998-05-11 MX MX9803706A patent/MX9803706A/es unknown
-
1999
- 1999-08-02 US US09/366,009 patent/US6426042B1/en not_active Expired - Fee Related
-
2001
- 2001-02-02 US US09/775,964 patent/US6949623B2/en not_active Expired - Fee Related
-
2005
- 2005-07-14 US US11/181,091 patent/US7446170B2/en not_active Expired - Fee Related
-
2008
- 2008-09-30 US US12/241,581 patent/US7790849B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3343357B2 (ja) | 2002-11-11 |
CN1207774A (zh) | 1999-02-10 |
KR19990067446A (ko) | 1999-08-16 |
EP0870839A1 (en) | 1998-10-14 |
EA200001110A1 (ru) | 2001-06-25 |
US7790849B2 (en) | 2010-09-07 |
US20090209730A1 (en) | 2009-08-20 |
KR100353115B1 (ko) | 2003-01-06 |
EP0870839B1 (en) | 2006-05-10 |
EA003204B1 (ru) | 2003-02-27 |
US6472204B1 (en) | 2002-10-29 |
AU7505896A (en) | 1997-06-05 |
ATE325884T1 (de) | 2006-06-15 |
WO1997018318A1 (en) | 1997-05-22 |
AU709831B2 (en) | 1999-09-09 |
EA003195B1 (ru) | 2003-02-27 |
EP0870839A4 (en) | 2000-01-19 |
US20060030046A1 (en) | 2006-02-09 |
EA004928B1 (ru) | 2004-10-28 |
KR100395420B1 (ko) | 2003-08-21 |
DE69636122D1 (de) | 2006-06-14 |
US6426042B1 (en) | 2002-07-30 |
DE69636122T2 (de) | 2006-12-07 |
EA200200837A1 (ru) | 2002-12-26 |
EA199800369A1 (ru) | 1998-12-24 |
ES2259182T3 (es) | 2006-09-16 |
US20030087437A1 (en) | 2003-05-08 |
CA2235629A1 (en) | 1997-05-22 |
US6949623B2 (en) | 2005-09-27 |
US7446170B2 (en) | 2008-11-04 |
CN100390290C (zh) | 2008-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9803706A (es) | Metodo para transferir genes dentro de celulas objetivo, con retrovirus. | |
CA2163781A1 (en) | Method and Apparatus for Conducting an Array of Chemical Reactions on a Support Surface | |
NO992167D0 (no) | Preparater og fremgangsmÕter for immobilisering av nukleinsyrer til faste bµrere | |
BG101103A (en) | Mammalian telomerase | |
IL128003A (en) | MULTISPECIFIC BINDING MOLECULES COMPRISING A BINDING DETERMINANT WHICH BINDS AN FCalpha RECEPTOR | |
NZ331189A (en) | Method of detection of influenza virus using neuraminidase binders | |
MX9603532A (es) | Sistema de suministro de acido nucleico, metodo de sintesis y sus usos. | |
WO2000044389A3 (fr) | Procede de preparation de vesicules membranaires | |
AU1884392A (en) | Peptide nucleic acids | |
IL195605A0 (en) | Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms | |
EP0861262A4 (en) | GROUPS FOR CATCHING NUCLEIC ACIDS | |
AU6058094A (en) | Internal controls for iosthermal nucleic acid amplification reactions | |
AU2284697A (en) | Fusogenic liposomes | |
AU1530401A (en) | Security system | |
WO1996001614A3 (en) | Rna component of telomerase | |
WO1999016791A3 (en) | Compounds and methods for regulating cell adhesion | |
AU3143897A (en) | Oligonucleotides which specifically bind retroviral nucleocapsid proteins | |
AU3677095A (en) | Radioactive phosphorous labeling of proteins for targeted radiotherapy | |
CA2265444A1 (en) | Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods | |
WO2004037198A3 (en) | Antibody-mediated induction of tumor cell death | |
WO2003008578A3 (en) | Reagents and methods for identifying gene targets for treating cancer | |
IE64781B1 (en) | Immunoglobulin conjugates | |
CA2038577A1 (en) | Utilization and delivery of enzymes | |
NZ337924A (en) | Site-specific drug delivery compounds comprising an anchoring moiety, a linking group and a drug | |
ES2185024T3 (es) | Procedimiento que permite mejorar el rendimiento de un reactivo inmunologico en un dosificado inmunologico. |